ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 164 filers reported holding ARGENX SE in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,427,498 | +2568.1% | 59,857 | +2015.1% | 0.02% | +2100.0% |
| Q2 2023 | $1,102,937 | +95.5% | 2,830 | +86.9% | 0.00% | – |
| Q1 2023 | $564,086 | +20.8% | 1,514 | +22.8% | 0.00% | – |
| Q4 2022 | $467,098 | -10.5% | 1,233 | -16.8% | 0.00% | – |
| Q3 2022 | $522,000 | +4.0% | 1,482 | +12.0% | 0.00% | – |
| Q2 2022 | $502,000 | +6.8% | 1,323 | -11.1% | 0.00% | – |
| Q1 2022 | $470,000 | +0.2% | 1,489 | +11.1% | 0.00% | – |
| Q4 2021 | $469,000 | -18.6% | 1,340 | -29.7% | 0.00% | – |
| Q3 2021 | $576,000 | -68.3% | 1,907 | -68.4% | 0.00% | -100.0% |
| Q2 2021 | $1,816,000 | +63.2% | 6,033 | +49.3% | 0.00% | 0.0% |
| Q1 2021 | $1,113,000 | +5.8% | 4,040 | +12.8% | 0.00% | 0.0% |
| Q4 2020 | $1,052,000 | +14.2% | 3,580 | +2.1% | 0.00% | 0.0% |
| Q3 2020 | $921,000 | +13.4% | 3,508 | -2.8% | 0.00% | 0.0% |
| Q2 2020 | $812,000 | +141.7% | 3,608 | +41.7% | 0.00% | – |
| Q1 2020 | $336,000 | -4.8% | 2,547 | +16.0% | 0.00% | – |
| Q4 2019 | $353,000 | -90.6% | 2,196 | -93.3% | 0.00% | -100.0% |
| Q3 2019 | $3,755,000 | -35.9% | 32,946 | -20.4% | 0.00% | -40.0% |
| Q2 2019 | $5,858,000 | +20.4% | 41,380 | +6.2% | 0.01% | 0.0% |
| Q1 2019 | $4,865,000 | +53.1% | 38,973 | +17.9% | 0.01% | +66.7% |
| Q4 2018 | $3,177,000 | +87.5% | 33,067 | +48.0% | 0.00% | +50.0% |
| Q3 2018 | $1,694,000 | – | 22,343 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |